Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
about
Identification of genes differentially expressed in T cells following stimulation with the chemokines CXCL12 and CXCL10Gene from a psoriasis susceptibility locus primes the skin for inflammationCatestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokinesThe cell biology of acute itchNovel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approachEpidermal RAF prevents allergic skin diseaseTranscriptomic analysis of the temporal host response to skin infestation with the ectoparasitic mite Psoroptes ovisGenetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients.Serum mucosa-associated epithelial chemokine in atopic dermatitis: a specific marker for severityProteome and cytokine serum profiling to diagnose a mycosis fungoides.Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor.Gene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinaeTargeted disruption of MAIL, a nuclear IkappaB protein, leads to severe atopic dermatitis-like disease.Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases.Resveratrol enhances solar UV-induced responses in normal human epidermal keratinocytes.Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium.CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation.Advances in the management of psoriasis: monoclonal antibody therapies.Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin.Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo.Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitorPeripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.CCR6 as a possible therapeutic target in psoriasis.Infliximab (Remicade) in the treatment of psoriatic arthritis.Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.Pathway analysis of differentially expressed genes in patients with acute aortic dissection.Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.Chemokine receptors in psoriasis.Cytokines in terms of QSAR. Review, evaluation and comparative studies.Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors.Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis. Recruitment of the epidermal growth factor receptor and activation of MAP kinases.CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor.Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis.Atopic Dermatitis Studies through In Vitro Models.Mixture of Polyphenols and Anthocyanins from Vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice.CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.Anti-inflammatory and Anti-oxidative Effects of Korean Red Ginseng Extract in Human Keratinocytes.Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases.
P2860
Q21263139-D559FD1D-ED48-4699-A939-7CF5D17B8737Q24314913-FE942ECA-7BB2-4377-AB99-0EA8500E8CC6Q24324814-612277D5-75EB-4A4E-8DF1-F852C7439F47Q28074326-52DA6527-4B03-4E14-B94A-A1422C96D6F1Q28535430-F674C302-56B2-4E27-A637-C92A894EBA48Q28829587-ED738C25-6CCD-4745-BDE6-2E7136517CACQ30500185-B702D4FF-8B1A-4F60-96FB-888C0BFC57B8Q33340314-694B1049-6399-4076-B1C9-8543FF1C1623Q33607633-F3477FCB-040D-4A0E-85DC-3AE68E11BC45Q33959656-07667FED-ADE2-49B0-AE70-44547AF84830Q34272784-ADC65949-B530-4F85-B002-FAF720F8BECEQ34351982-D0CF3CB5-CBD3-4834-80FE-71862C1110BFQ34360013-D2067D5A-9968-416E-A139-05033AA8B2D5Q34487589-E9D9495C-48C9-4106-9B12-C9C2C341E180Q34639954-7C072ED1-AB44-4A33-8B11-6F94BB479EDCQ34647617-2D36774B-2D43-4A46-9210-B255C665F904Q35017873-909A3D0D-78F2-4C00-B458-75A0784AE13AQ35030921-735A2ED2-D588-48B8-BCCA-B03B9B91A0E3Q35633397-700E6CB1-9C57-4D57-AA5F-3922E85A00B3Q35789250-AF54C2F4-60B5-48D9-B6FD-7C977606D82AQ35791607-481E455C-9DCC-4C0A-9CF6-5D487DA06F11Q35842929-9EA4747C-CF97-4B26-828D-1EEDF36F8E49Q35945026-B1E7F17A-1F3C-4CAF-A819-1B3BB2FB938BQ36307704-106B945C-9892-44BD-8E5A-763765B52B54Q36980670-BEEB1743-F9A0-41F7-B365-1ACE0BFFDDB0Q37116853-00BAD218-6F97-4FAF-8FF8-8F32B41692E1Q37175410-08149683-34D8-4DD3-8B66-293830D5CA7EQ37277608-7B35F4E5-A0B4-4BFB-9A50-961313BE1F47Q37690234-24827FD7-BF0C-4DFC-AFFA-D1100C47D2A1Q38144211-961E970C-162C-4E73-906E-F7852A940A7EQ38149987-FAB7ED00-BC84-4A14-9A61-53A8C8F5974BQ38207484-23D70D03-0E1F-4C42-A83F-CACABC98E653Q40058239-75FA3335-B4B8-4DE9-A4C3-3ACE09F6987CQ40179624-88635E96-39FF-4E48-B4F4-3F5841CE6C52Q40554749-65B18089-EABF-41E5-83A5-D098C5ADDE35Q41101918-EB94A54C-2BD7-48E2-ACEE-0C3892D00761Q41568932-1281B234-0466-46CB-A74B-D55BBC0D8320Q42519791-FA448589-9FE3-4C18-98B3-9C2D74BD1F8CQ42712680-F601571D-B0A7-4DC5-B9FB-3B141B159DCBQ44899449-068E8920-B100-460D-981D-9BEB4C7D83AB
P2860
Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
description
2001 nĆ® lÅ«n-bĆ»n
@nan
2001幓ć®č«ę
@ja
2001幓å¦ęÆęē«
@wuu
2001幓å¦ęÆęē«
@zh-cn
2001幓å¦ęÆęē«
@zh-hans
2001幓å¦ęÆęē«
@zh-my
2001幓å¦ęÆęē«
@zh-sg
2001幓åøč”ęē«
@yue
2001幓åøč”ęē«
@zh
2001幓åøč”ęē«
@zh-hant
name
Keratinocytes from patients wi ...... e to T cell-derived cytokines.
@en
Keratinocytes from patients wi ...... e to T cell-derived cytokines.
@nl
type
label
Keratinocytes from patients wi ...... e to T cell-derived cytokines.
@en
Keratinocytes from patients wi ...... e to T cell-derived cytokines.
@nl
prefLabel
Keratinocytes from patients wi ...... e to T cell-derived cytokines.
@en
Keratinocytes from patients wi ...... e to T cell-derived cytokines.
@nl
P2093
P356
P1476
Keratinocytes from patients wi ...... e to T cell-derived cytokines.
@en
P2093
Frezzolini A
Giannetti A
Girolomoni G
Giustizieri ML
P304
P356
10.1067/MAI.2001.114707
P407
P577
2001-05-01T00:00:00Z